InteRNA Technologies Publishes Preclinical Data from Investigational microRNA INT-1B3 Program in Molecular Therapy – Nucleic Acids and Oncotarget

24 March, 2021

Click here to read more

EVENTS

22 September 2021 - 23 September 2021

Oligonucleotide Therapeutics and Delivery, Virtual Conference, United Kingdom

07 October 2021 - 11 October 2021

AACR VIRTUAL INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS

25 October 2021 - 28 October 2021

BIO-Europe® Digital

08 November 2021 - 15 November 2021

LSX’s Inv€$tival ShowcaseTM, Online & Physical, London, United Kingdom

16 November 2021 - 19 November 2021

8th China Healthcare Summit, Online & Physical , Shanghai Shi, China

NEWS

24 March, 2021

InteRNA Technologies Publishes Preclinical Data from Investigational microRNA INT-1B3 Program in Molecular Therapy – Nucleic Acids and Oncotarget

21 March, 2021

InteRNA and the renewed interest in RNA therapeutics in the March 2021 edition of MedNous

11 March, 2021

InteRNA Technologies Awarded € 2.7M Clinical Innovation Credit from Dutch Government

16 February, 2021

InteRNA Technologies Announces Dosing of First Patient in First-in-Human Trial of microRNA Drug Candidate INT-1B3 in Patients with Advanced Solid Tumors

9 February, 2021

InteRNA Technologies Extends Series B Financing Round Totaling EUR 18.5M

1-5 6-10 11-15 16-20 21-25 26-30 31-35 36-40 41-41